All companies
Visit website
Liton Rx
OperatingLitonRx, Inc.
Healthcare · Technology · Founded 2022
Digital solution to your prescriptions
Post-money valuation ⓘ
$25.1M
As of Dec 2022 · from Liton Rx Common Stock 1 · pre-money + amount raised, not a traded price
Total raised
$121,400
Across 1 round since 2022
Latest share price
$1.00
Liton Rx Common Stock 1 offering price
Financials
FY2020–FY2021 · from SEC filings · hover any figure for its source$0
−$70K
2020
$518K
−$530K
2021
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2020
FY2021
Income statement
Revenue
$0
$518,090
Cost of goods sold
$0
$471,419
Gross margin
—
9%
Net income
-$69,584
-$530,361
Taxes paid
$0
$0
Balance sheet
Cash
$16,451
$506,175
Accounts receivable
$0
$71,879
Total assets
$27,851
$801,961
Short-term debt
$3,422
$35,675
Long-term debt
$0
$0
Total liabilities
$3,422
$35,675
Other
Headcount
—
4
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$25.1M
post-money
Liton Rx Common Stock 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $121.4K / $1.2MInvestors 17Post-money $25.1M
Reg CF annual-report compliance
Delinquent
Filed 0 of 4 annual reports (FY2022–FY2025)
Missing: 2022, 2023, 2024, 2025
17 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0001942648Share price $1.00
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.